Nanomedicine and Molecular Imaging Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Dublin, Ireland.
Laboratory of Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1738. doi: 10.1002/wnan.1738. Epub 2021 Jul 12.
Nanomaterials are highly susceptible to endotoxin contamination due their large surface-to-volume ratios and endotoxins propensity to associate readily to hydrophobic and cationic surfaces. Additionally, the stability of endotoxin ensures it cannot be removed efficiently through conventional sterilization techniques such as autoclaving and ionizing radiation. In recent times, the true significance of this hurdle has come to light with multiple reports from the United States Nanotechnology Characterization Laboratory, in particular, along with our own experiences of endotoxin testing from multiple Horizon 2020-funded projects which highlight the importance of this issue for the clinical translation of nanomaterials. Herein, we provide an overview on the topic of endotoxin contamination of nanomaterials intended for biomedical applications. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine.
纳米材料由于其较大的表面积与体积比,以及内毒素易于与疏水性和阳离子表面结合的特性,极易受到内毒素污染。此外,内毒素的稳定性确保了它不能通过传统的灭菌技术(如高压灭菌和电离辐射)有效地去除。最近,美国纳米技术表征实验室(United States Nanotechnology Characterization Laboratory)的多份报告以及我们自己在多个欧盟地平线 2020 资助项目中的内毒素检测经验,揭示了这一障碍的真正意义,突出了这个问题对于纳米材料向临床转化的重要性。本文就生物医学应用纳米材料的内毒素污染问题进行综述。本文属于以下分类:治疗方法和药物发现 > 新兴技术 纳米药物毒理学和监管问题 > 纳米药物的监管和政策问题。